https://apnews.com/08d7d402fc20b371436898534f728f2e

ROME (AP) — A top official at the European Medicines Agency said in an interview published Tuesday there is a causal link between AstraZeneca's coronavirus vaccine and rare blood clots, but that it's still unclear what the connection is and the benefits of taking the vaccine outweigh the risks of getting COVID-19.

Marco Cavaleri, head of health threats and vaccine strategy at the Amsterdam-based agency, told Rome's Il Messaggero newspaper that the EU medicines regulator is preparing to make a more definitive statement this week.